Apyx Medical (APYX) Cash from Financing Activities (2011 - 2026)
Apyx Medical's (APYX) quarterly Cash from Financing Activities came in at -$5000.0 in Q2 2026, down 120.0% on a YoY basis from $25000.0 in Q2 2025, and down 106.02% quarter-over-quarter from $83000.0 in Q1 2026.
Powered by 
Analysis
Apyx Medical (APYX) Cash from Financing Activities (2011 - 2026) Analysis & Trends
Apyx Medical (APYX) has reported Cash from Financing Activities for 16 consecutive years, with -$5000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash from Financing Activities fell 120.0% year-over-year to -$5000.0; the trailing twelve-month figure through Jun 2026 stood at $9.6 million (up 41.19% YoY), and the FY2025 full-year result was $9.6 million, up 42.03% from the prior year.
- Cash from Financing Activities fell to -$5000.0 in Q2 2026 per APYX's latest filing, from $83000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $23.8 million in Q4 2023 and bottomed at -$10000.0 in Q4 2022.
- Historically, Cash from Financing Activities has averaged $2.7 million across 5 years, with a median of $45500.0 in 2023.
- The sharpest annual moves came in 2023 and 2026: Cash from Financing Activities jumped 238540.0% in 2023, then tumbled 120.0% in 2026.
- Over 5 years, Cash from Financing Activities stood at -$10000.0 in 2022, then surged by 238540.0% to $23.8 million in 2023, then sank by 71.65% to $6.8 million in 2024, then surged by 40.31% to $9.5 million in 2025, then sank by 100.05% to -$5000.0 in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered -$5000.0, $83000.0, and $9.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.77 Bn | 175.17 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 127.65 Bn | 122.43 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 117.15 Bn | 108.33 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 104.21 Bn | 100.73 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 63.46 Bn | 62.92 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 49.73 Bn | 45.48 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 33.01 Bn | 31.56 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 32.17 Bn | 30.22 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Steris | 20.72 Bn | 20.24 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Apyx Medical | 130.67 Mn | 103.06 Mn | 8.87 Mn | -5,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5,000.00 |
| Mar 31, 2026 | 83,000.00 |
| Dec 31, 2025 | 9.49 Mn |
| Sep 30, 2025 | 45,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Dec 31, 2024 | 6.76 Mn |
| Sep 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Dec 31, 2023 | 23.84 Mn |
| Sep 30, 2023 | 164,000.00 |
| Jun 30, 2023 | 46,000.00 |
| Mar 31, 2023 | 8.11 Mn |
| Dec 31, 2022 | -10,000.00 |
| Sep 30, 2022 | 127,000.00 |
| Jun 30, 2022 | 2,000.00 |
| Mar 31, 2022 | 98,000.00 |
| Dec 31, 2021 | -39,000.00 |
| Sep 30, 2021 | -33,000.00 |